Overview
Sotac Pharmaceuticals Limited is a pharmaceutical manufacturing company in Gujarat, India, specializing in a wide range of pharmaceutical products under loan licensing or contract manufacturing partnerships.
The company has a robust portfolio covering therapeutic areas such as anti-diabetics, anti-psychotics, and antibiotics, serving a broad client base in pharmaceutical development and production.
In 2022, Sotac Pharmaceuticals expanded strategically by acquiring holdings in SOTAC Healthcare and SOTAC Research, indicating a significant shift towards enhancing its research and healthcare capabilities.
The company went public with an IPO in April 2023, raising Rs 33 crore, which will likely support its expansion and operational initiatives.
Sotac Pharmaceuticals has been on a growth trajectory since its establishment, now operating as a public limited company, reflecting increasing trust and ambition within the pharmaceutical sector.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
129 Cr
- Volatility
Low Risk
- P/E Ratio
24.4
- Industry P/E
32.3
- PEG Ratio
1.9
- P/B Ratio
2.4
- 52W High
152.35
- 52W Low
100.00
Financial Ratios
Sales CAGR
- 1Y
- -6.59%
- 3Y
- -5.17%
- 5Y
- 16.81%
- 10Y
- —
Profit CAGR
- 1Y
- 159.22%
- 3Y
- 13.13%
- 5Y
- 31.15%
- 10Y
- —
ROE
- TTM
- 15.37%
- 3Y
- 12.28%
- 5Y
- 14.75%
- 10Y
- —
ROCE
- TTM
- 16.39%
- 3Y
- 16.64%
- 5Y
- 19.16%
- 10Y
- —
Technicals
Oscillators
Bearish
Bearish
6
Neutral
5
Bullish
3
Overall
Bullish
Bearish
10
Neutral
13
Bullish
23
Moving Averages
Bullish
Bearish
4
Neutral
8
Bullish
20
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
